WASHINGTON, Nov. 5, 2004 -- -- When the president of a small California biotech firm heard of a promising new treatment for lung cancer, he was intrigued. "It stimulates a very strong immune response ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback